1 |
Maiarù M, Leese C, Certo M, et al. Selective neuronal silencing using synthetic botulinum molecules alleviates chronic pain in mice[J]. Sci Transl Med, 2018, 10 (450): 7384.
|
2 |
Walter U, Dudesek A, Fietzek UM. A simplified ul-trasonography-guided approach for neurotoxin injection into the obliquus capitis inferior muscle in spasmodic torticollis[J]. J Neural Transm (Vienna), 2018, 125 (7): 1037-1042.
|
3 |
Roman J, Zampella JG. Demographics of men and minorities in cosmetic clinical trials of botulinum toxin and hyaluronic acid fillers[J]. Dermatol Surg, 2020, 46 (9): 1164-1168.
|
4 |
Kwolek MS, Block JE. Maximizing botulinum toxin injections for cosmetic and therapeutic applications with a single use, disposable, exact dose injection assist device[J]. Clin Cosmet Investig Dermatol, 2019 (12): 35-46.
|
5 |
Intiso D, Basciani M. Botulinum toxin use in neuro-rehabilitation to treat obstetrical plexus palsy and sialorrhea following neurological diseases: a review[J]. NeuroRehabilitation, 2012, 31 (2): 117-129.
|
6 |
Simpson LL. The origin, structure, and pharmacological activity of botulinum toxin[J]. Pharmacol Rev, 1981, 33 (3): 155-188.
|
7 |
Go EJ, Ji J, Kim YH, et al. Transient receptor poten-tial channels and botulinum neurotoxins in chronic pain[J]. Front Mol Neurosci, 2021 (14): 772719.
|
8 |
Lo C, Mertz D, Loeb M. Newcastle-Ottawa scale: com-paring reviewers′ to authors′ assessments[J]. BMC Med Res Methodol, 2014 (14): 45.
|
9 |
Abbasian M, Baghbani S, Barangi S, et al. Outcomes of ultrasound-guided gastrocnemius injection with botulinum toxin for chronic plantar fasciitis[J]. Foot Ankle Int, 2020, 41 (1): 63-68.
|
10 |
Wu T, Song HX, Li YZ, et al. Clinical effectiveness of ultrasound guided subacromial-subdeltoid bursa injection of botulinum toxin type A in hemiplegic shoulder pain: a retrospective cohort study[J]. Medicine (Baltimore), 2019, 98 (45): e17933.
|
11 |
Galván Ruiz A, Vergara Díaz G, Rendón Fernández B, et al. Effects of ultrasound-guided administration of botulinum toxin (incobotulinumtoxinA) in patients with lateral epicondylitis[J]. Toxins (Basel), 2019, 11 (1): 46.
|
12 |
Artusi CA, Bortolani S, Merola A, et al. Botulinum toxin for Pisa syndrome: an MRI-, ultrasound-and electromyography-guided pilot study[J]. Parkinsonism Relat Disord, 2019 (62): 231-235.
|
13 |
Rodríguez-Pinero M, Vidal Vargas V, Jiménez Sarmiento AS. Long-term efficacy of ultrasound-guided injection of incobotulinumtoxinA in piriformis syndrome[J]. Pain Med, 2018, 19 (2): 408-411.
|
14 |
Al-Al-Shaikh M, Michel F, Parratte B, et al. An MRI evaluation of changes in piriformis muscle morphology induced by botulinum toxin injections in the treatment of piriformis syndrome[J]. Diagn Interv Imaging, 2015, 96 (1): 37-43.
|
15 |
Huang YC, Wei SH, Wang HK, et al. Ultrasono-graphic guided botulinum toxin type A treatment for plantar fasciitis: an outcome-based investigation for treating pain and gait changes[J]. J Rehabil Med, 2010, 42 (2): 136-140.
|
16 |
Dressler D. Botulinum toxin drugs: brief history and outlook[J]. J Neural Transm (Vienna), 2016, 123 (3): 277-279.
|
17 |
Zhai S, Huang B, Yu K. The efficacy and safety of botulinum toxin type A in painful knee osteoarthritis: a systematic review and meta-analysis[J]. J Int Med Res, 2020, 48 (4): 300060519895868.
|
18 |
Suzuki M, Saito N, Naritaka N, et al. Scoring system for the prediction of severe acute pancreatitis in children[J]. Pediatr Int, 2015, 57 (1): 113-118.
|
19 |
Meng J, Wang J, Lawrence G, et al. Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential[J]. J Cell Sci, 2007, 120 (Pt 16): 2864-2874.
|
20 |
Cui M, Khanijou S, Rubino J, et al. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain[J]. Pain, 2004, 107 (1-2): 125-133.
|
21 |
Chuang YC, Yoshimura N, Huang CC, et al. Intrapro-static botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat[J]. J Urol, 2008, 180 (2): 742-748.
|
22 |
Wei J, Zhu X, Yang G, et al. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: a meta-analysis of randomized controlled trials[J]. Brain Behav, 2019, 9 (10): e01409.
|